LakeShore Biopharma Aktie - LSB

LakeShore Biopharma Company Ltd (LSB) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

0,627

( - )

Gebot

0,644

Fragen

0,6441

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

0,627

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting

LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting PR Newswire BEIJING, Sept. 22, 2025 BEIJING, Sept. 22, 2025...

LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq

LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq PR Newswire BEIJING, Sept. 12, 2025 BEIJING, Sept. 12, 2025...

LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee PR Newswire BEIJING, Sept...

LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee

LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee PR...

LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company

LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company PR Newswire BEIJING, Aug. 18, 2025 BEIJING...

LakeShore Biopharma Announces Fiscal Year 2025 Financial Results

LakeShore Biopharma Announces Fiscal Year 2025 Financial Results PR Newswire BEIJING, July 31, 2025 Total revenue reached RMB615.0 million...

LakeShore Biopharma Announces US$15 Million Private Placement Financing

LakeShore Biopharma Announces US$15 Million Private Placement Financing PR Newswire BEIJING, July 8, 2025 BEIJING, July 8, 2025 /PRNewswire/...

LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell)

LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell) PR Newswire BEIJING, April...

LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance

LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance PR...

LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China

BEIJING, Dec. 12, 2024 (GLOBE NEWSWIRE) -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) (“LakeShore Biopharma”...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

LSB - Frequently Asked Questions (FAQ)

What is the current LakeShore Biopharma Company Ltd share price?

The current share price of LakeShore Biopharma Company Ltd is US$ 0,627

What is the 1 year trading range for LakeShore Biopharma Company Ltd share price?

LakeShore Biopharma Company Ltd has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

LakeShore Biopharma Company Ltd (LSB)

LakeShore Biopharma Company Ltd (LSB) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

LSB Neueste Nachrichten

LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting

LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq

LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee

LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company

LakeShore Biopharma Announces Fiscal Year 2025 Financial Results

LakeShore Biopharma Announces US$15 Million Private Placement Financing

LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell)

LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance

LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China

LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting

LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq

LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee

LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company

LakeShore Biopharma Announces Fiscal Year 2025 Financial Results

LakeShore Biopharma Announces US$15 Million Private Placement Financing

LSB - Frequently Asked Questions (FAQ)

LSB Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

LakeShore Biopharma Company Ltd (LSB)

LakeShore Biopharma Company Ltd (LSB) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

LSB Neueste Nachrichten

LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting

LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq

LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee

LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company

LakeShore Biopharma Announces Fiscal Year 2025 Financial Results

LakeShore Biopharma Announces US$15 Million Private Placement Financing

LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell)

LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance

LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China

LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting

LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq

LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee

LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company

LakeShore Biopharma Announces Fiscal Year 2025 Financial Results

LakeShore Biopharma Announces US$15 Million Private Placement Financing

LSB - Frequently Asked Questions (FAQ)

LSB Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich GRATIS und erhalten Sie:

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS